Term Description


Approved pathology authority.


Approved pathology provider.


Compound annual growth rate, or the average annual growth rate over a specified time period.


Describes when the item and/or its services will be affected by the recommendations. This could result from a range of recommendations, such as: (i) specific recommendations that affect the services provided by changing item descriptors or explanatory notes, (ii) the consolidation of item numbers, and (iii) splitting item numbers (e.g. splitting the current services provided across two or more items).


Describes when an item is recommended for removal from the MBS and its services will no longer be provided under the MBS.


Financial year


General practitioner


Glycated haemoglobin

High-value care

Services of proven efficacy reflecting current best medical practice, or for which the potential benefit to consumers exceeds the risk and costs.

Inappropriate use/misuse

Use of MBS services for purposes other than those intended. This includes a range of behaviours, from failing to adhere to particular item descriptors or rules through to deliberate fraud.

Low-value care

Use of an intervention that evidence suggests confers little benefit or no benefit to patients; or when the risk of harm from the intervention exceeds the likely benefit; or, more broadly, when the added costs of the intervention do not provide proportional added benefits.


Medicare Benefits Schedule

MBS item

An administrative object listed in the MBS and used for the purposes of claiming and paying Medicare benefits, consisting of an item number, service descriptor and supporting information, schedule fee and Medicare benefits.

MBS service

The actual medical consultation, procedure or test to which the relevant MBS item refers.


Medical Services Advisory Committee

Multiple services rules

A set of rules governing the amount of Medicare benefit payable for multiple services provided to a patient at the same attendance (same day).

New service

Describes when a new service has been recommended, with a new item number. In most circumstances these will need to go through MSAC. It is worth noting that implementation of the recommendation may result in more or fewer item numbers than specifically stated.

No change or unchanged

Describes when the services provided under these items will not be changed or affected by the recommendations. This does not rule out small changes in item descriptors (e.g. references to other items, which may have changed as a result of the MBS Review or prior reviews).

Obsolete services/items

Services that should no longer be performed, as they do not represent current clinical best practice and have been superseded by superior tests or procedures.


Oral glucose challenge test


Oral glucose tolerance test

Pathology episode coning

An arrangement governing the amount of Medicare benefit payable for multiple pathology services performed in a single patient episode. When more than three pathology services are requested by a GP in a patient episode, the benefits payable are equivalent to the sum of the benefits for the three items with the highest schedule fees.


Pharmaceutical Benefits Scheme


Royal Australian College of General Practitioners


Thyroid function tests

The Taskforce

MBS Review Taskforce


Thyroid stimulating hormone